Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension

US Patent 7314871 · Granted Jan 1, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted dihydroquinazolines2023
Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives2022
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
Branched 3-phenylpropionic acid derivatives and their use2022
Orally administrable modified-release pharmaceutical dosage form2022
Orally administrable modified-release pharmaceutical dosage form2021
Substituted 5-fluoro-1H-pyrazolopyridines and their use2020
(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use2020
Substituted oxopyridine derivatives2019
Branched 3-phenylpropionic acid derivatives and their use2019
Substituted oxopyridine derivatives and use thereof cardiovascular disorders2019